Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Sotigalimab (anti-CD40)
Price: Check
Purity: 95.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

2305607-45-6

2305607-45-6 structure

2305607-45-6 structure

Name: Sotigalimab
Chemical Name: Sotigalimab
CAS Number: 2305607-45-6
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Cancer
Create Date: 2022-08-23 18:53:20
Modify Date: 2024-09-18 16:42:03
Sotigalimab, a CD40 agonistic monoclonal antibody, can be used for the research of metastatic pancreatic adenocarcinoma[1].

Name	Sotigalimab

Description	Sotigalimab, a CD40 agonistic monoclonal antibody, can be used for the research of metastatic pancreatic adenocarcinoma[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
References	[1]. Mark H O'Hara, et al. CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. Lancet Oncol. 2021 Jan;22(1)

No Any Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.